Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
DYAX > SEC Filings for DYAX > Form 8-K on 2-Apr-2013All Recent SEC Filings

Show all filings for DYAX CORP | Request a Trial to NEW EDGAR Online Pro

Form 8-K for DYAX CORP


2-Apr-2013

Termination of a Material Definitive Agreement


Item 1.02. Termination of a Material Definitive Agreement.

On March 27, 2013, Dyax and Sigma Tau Rare Diseases S.A. entered into a termination agreement pursuant to which they terminated their Joint Development and License Agreement dated June 18, 2010, as amended to date (the "License Agreement"). As a result of this termination agreement, Sigma Tau has returned to Dyax all of the rights to develop and commercialize Kalbitor® (ecallantide) in Europe, Russia, Australia and New Zealand.

The principal terms of the termination agreement include provision for (i) the revocation of all licenses granted by Dyax to Sigma Tau, (ii) the termination of all other obligations under the License Agreement, (iii) the issuance to Sigma Tau of 271,665 shares of Dyax common stock, and (iv) the right of Sigma Tau to receive $500,000 for every $5,000,000 of compensation received by Dyax during the next ten years in relation to the license or supply of ecallantide in those territories that had been previously licensed to Sigma Tau.

Dyax will issue the shares of Dyax common stock to Sigma Tau in reliance on an exemption from registration under the Securities Act of 1933 pursuant to Section 4(2) thereof.


  Add DYAX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for DYAX - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.